Everyone's Quitting

























Doesn't matter how many shares you get in hire. Do the math. Value is high now. Many of us hired in last year 18 months were under water until this last pop. Hope it stays high so I can get my one year roll and leave. It's high now. It will have to go that much higher to be if any meaning to you in a year , two, three, ....small return on time investment.
 












Great comment above. Mass exodus happening. Stay away if you care about your career or sanity

There are seven RAM positions listed on the website. Are those new positions, or people that have been let go or left on their own? If it's turnover, then it seems like a lot because I believe the sales force is small.
 












Doesn't matter how many shares you get in hire. Do the math. Value is high now. Many of us hired in last year 18 months were under water until this last pop. Hope it stays high so I can get my one year roll and leave. It's high now. It will have to go that much higher to be if any meaning to you in a year , two, three, ....small return on time investment.


Clinical trial failure in transplant is a big blow. They also failed the previously hailed STEC indication as well. No confidence in the clinical team to deliver with Squinto gone now.
 






Clinical trial failure in transplant is a big blow. They also failed the previously hailed STEC indication as well. No confidence in the clinical team to deliver with Squinto gone now.

And we ask and ask "what ever happened to our second drug for HPP. "
They started a sales team a year ago. Answer "crickets"
 












Clinical trial failure in transplant is a big blow. They also failed the previously hailed STEC indication as well. No confidence in the clinical team to deliver with Squinto gone now.

It isn't just a failure in all the pipeline indications. KOLs are raising more and more issues around extravascular hemolysis with eculizumab
 
















































I would say as an insider that folks that are leaving most were "poison" individuals that were there to collect $$$$$. Now that actual work is needed to be accomplished in order to launch next drug successfully, they are leaving. Definitely a changing of the guard here in which they seem to be bringing in younger, talented individuals that have potential to move the company forward. Just my two cents. It is a hectic environment for those that don't know what it is to actually make decisions and put in the effort.